Monroe Capital Backs Battery Ventures' Phigenics Investment with Senior Credit Facility
Event summary
- Monroe Capital provided a senior credit facility to support Battery Ventures' investment in Phigenics.
- Phigenics offers tech-enabled solutions for mitigating Legionella and waterborne pathogen risks in healthcare facilities.
- The company operates accredited laboratories and provides a proprietary software platform, phiAnalytics.
- Monroe Capital acted as sole lead arranger and administrative agent for the funding.
The big picture
This deal underscores the growing emphasis on tech-driven solutions in healthcare safety, particularly in water management. Monroe Capital's involvement highlights the increasing private credit support for specialized healthcare technologies. The investment in Phigenics aligns with broader trends of leveraging data analytics and IoT for regulatory compliance and operational efficiency in healthcare facilities.
What we're watching
- Market Expansion
- How Phigenics will leverage Battery Ventures' investment to scale its tech-enabled solutions in the healthcare sector.
- Regulatory Compliance
- Whether the company can sustain its growth while adhering to stringent water management regulations.
- Execution Risk
- The pace at which Phigenics integrates new technologies and expands its customer base post-investment.
Related topics
